The Continuous Renal Replacement Therapy Market Revenue is predicted to grow from US$ 1,214.6 billion in 2023 to US$ 2,771.6 billion in 2033. During the forecast period, the market is expected to grow at an 8.6% CAGR. In contrast to standard renal replacement therapies such as IHD, which take 4-6 hours, this therapy.